A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of PMG1015 A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ...
A Phase 1A, First in Human, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of PMG1015 in Healthy Volunteers A Phase 1A, First in Human, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Stud ...